IconMEX:ICLRN 87 EBIT per Share is MXN85.12 as of Mar. 2026. GuruFocus rates MEX:ICLRN with a GF Score™ of 87/100 and a GF Value™ of MXN2,479.74. The stock has 4 warning signs investors should review. Among 169 Medical Diagnostics & Research companies, Icon ranks worse than 57.99% on this metric.
Icon's EBIT per Share for the
three
months ended in Mar. 2026 was MXN40.97.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN85.12.
During the past 12 months, the average EBIT per Share Growth Rate of Icon was -15.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 6.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 12.20% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 11.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Icon's EBIT per Share or its related term are showing as below:
MEX:ICLRN'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -29.5 Med: 9.3 Max: 73.3
Current: 6.9
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Icon was 73.30% per year. The lowest was -29.50% per year. And the median was 9.30% per year.
MEX:ICLRN's 3-Year EBIT Growth Rate is ranked worse than 57.99% of 169
companies
in the Medical Diagnostics & Research industry
Industry Median: 12.5
vs MEX:ICLRN: 6.90
Icon's EBIT for the
three
months ended in Mar. 2026 was MXN3,166 Mil.
Icon (MEX:ICLRN) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Icon EBIT per Share Related Terms
Icon EBIT per Share Historical Data
* Premium members only.
The historical data trend for Icon's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN85.12
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Icon (MEX:ICLRN) has a EBIT per Share of MXN85.12 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Icon and its competitors. According to the industry distribution chart, Icon ranks #98 out of 169 companies in the Medical Diagnostics & Research industry, placing it in the top 58%.
Is Icon's EBIT per Share too high?
Icon's current EBIT per Share is MXN85.12. Based on the distribution chart, Icon ranks #98 out of 169 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Icon has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Icon's EBIT per Share compare to RVTY and CRL?
According to the Medical Diagnostics & Research industry distribution chart, Icon ranks #98 out of 169 companies for EBIT per Share. This places Icon in the lower half of its industry. The industry median EBIT per Share is 12.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Diagnostics & Research company?
The median EBIT per Share among Medical Diagnostics & Research companies is 12.50, based on 169 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Icon and its competitors. For the Medical Diagnostics & Research industry, the median EBIT per Share is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Icon's current EBIT per Share is MXN85.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icon stock overvalued right now?
Icon (MEX:ICLRN) has a current EBIT per Share of MXN85.12. The stock's GF Value™ is MXN2,479.74, compared to a current price of MXN1,850.28 — trading 25.4% below its estimated fair value. The current EBIT per Share is MXN85.12. Icon's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Icon (MEX:ICLRN), the current EBIT per Share is MXN85.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Icon (MEX:ICLRN) Overvalued in 2026?
Based on GuruFocus' analysis, Icon stock appears to be undervalued.
The current stock price of MXN1,850.28 is trading 25.4% below its estimated GF Value™ of MXN2,479.74.
Key valuation signals for MEX:ICLRN:
EBIT per Share: MXN85.12
GF Value™: MXN2,479.74 vs. price of MXN1,850.28 (25.4% below fair value)
No single metric tells the full story. See the MEX:ICLRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
87GF Score
Get the complete analysis for MEX:ICLRN
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ICLRN has been successfully added to your 
